Cosmo NV (XSWX:CMHC) 5-Year Dividend Growth Rate: 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:CMHC Cosmo NV XSWX:CMHC
81 GF Score
Price CHF57.10
GF Value CHF40.77
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Cosmo NV 5-Year Dividend Growth Rate?

Cosmo NV XSWX:CMHC -2.89% 81 5-Year Dividend Growth Rate is 0.00% as of Jun. 2026. GuruFocus rates XSWX:CMHC with a GF Score™ of 81/100 and a GF Value™ of CHF40.77 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 280 Drug Manufacturers companies, Cosmo NV ranks worse than 357142.5% on this metric.

Cosmo NV's Dividends per Share for the six months ended in Jun. 2026 was CHF1.93.

During the past 12 months, Cosmo NV's average Dividends Per Share Growth Rate was -49.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 26.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Cosmo NV was 26.80% per year. The lowest was 13.40% per year. And the median was 20.10% per year.

Cosmo NV's Dividend Payout Ratio for the six months ended in Jun. 2026 was 0.00. As of today, Cosmo NV's Dividend Yield % is 3.37%.

Good Sign:

Cosmo NV stock Dividend Yield % is close to 1-year high.

For more information regarding to dividend, please check our Dividend Page.


Cosmo NV  (XSWX:CMHC) 5-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Cosmo NV's Dividend Payout Ratio for the quarter that ended in Jun. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2026 )/ EPS without NRI (Q: Jun. 2026 )
=1.934/ -0.305
=N/A

During the past 13 years, the highest Dividend Payout Ratio of Cosmo NV was 1.10. The lowest was 0.25. And the median was 0.91.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Cosmo NV Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
EUR 2.1000002026-04-242026-04-272026-05-11Cash DividendannuallyEUR:CHF 0.915088

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Cosmo NV's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=1.9216848/57.10
=3.37 %

Current Share Price is CHF57.10.
Cosmo NV's Dividends per Share for the trailing twelve months (TTM) ended in Today is CHF1.9216848.

During the past 13 years, the highest Dividend Yield of Cosmo NV was 4.03%. The lowest was 0.84%. And the median was 1.56%.

Good Sign:

Cosmo NV stock Dividend Yield % is close to 1-year high.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cosmo NV 5-Year Dividend Growth Rate Related Terms


XSWX:CMHC vs LLY, JNJ, ABBV: 5-Year Dividend Growth Rate Comparison

For the Drug Manufacturers - General subindustry, Cosmo NV's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cosmo NV 5-Year Dividend Growth Rate vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cosmo NV's 5-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Cosmo NV's 5-Year Dividend Growth Rate falls into.


XSWX:CMHC
81GF Score
Cosmo NV XSWX:CMHC
5-Year Dividend Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cosmo NV 5-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

What does a 5-Year Dividend Growth Rate of 0.00% mean?
Cosmo NV (XSWX:CMHC) has a 5-Year Dividend Growth Rate of 0.00% as of Jun. 2026. 5-Year Dividend Growth Rate is the company's five-year average growth of dividend payout. View historical data on Cosmo NV and its competitors. According to the industry distribution chart, Cosmo NV ranks #999999 out of 280 companies in the Drug Manufacturers industry.
Is Cosmo NV's 5-Year Dividend Growth Rate too high?
Cosmo NV's current 5-Year Dividend Growth Rate is 0.00%. Based on the distribution chart, Cosmo NV ranks #999999 out of 280 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Cosmo NV has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cosmo NV's 5-Year Dividend Growth Rate compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Cosmo NV ranks #999999 out of 280 companies for 5-Year Dividend Growth Rate. This places Cosmo NV in the lower half of its industry. The industry median 5-Year Dividend Growth Rate is 10.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Dividend Growth Rate for a Drug Manufacturers company?
The median 5-Year Dividend Growth Rate among Drug Manufacturers companies is 10.20, based on 280 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Dividend Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Dividend Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Dividend Growth Rate mean?
A high 5-Year Dividend Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year Dividend Growth Rate is the company's five-year average growth of dividend payout. View historical data on Cosmo NV and its competitors. For the Drug Manufacturers industry, the median 5-Year Dividend Growth Rate is 10.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cosmo NV's current 5-Year Dividend Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmo NV stock overvalued right now?
Based on GuruFocus' analysis, Cosmo NV (XSWX:CMHC) is currently considered Significantly Overvalued. The stock's GF Value™ is CHF40.77, compared to a current price of CHF57.10 — trading 40.1% above its estimated fair value. The current 5-Year Dividend Growth Rate is 0.00%. Cosmo NV's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Dividend Growth Rate calculated?
5-Year Dividend Growth Rate is calculated from a company's financial statements. For Cosmo NV (XSWX:CMHC), the current 5-Year Dividend Growth Rate is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cosmo NV (XSWX:CMHC) Overvalued in 2026?

Based on GuruFocus' analysis, Cosmo NV stock appears to be overvalued. The current stock price of CHF57.10 is trading 40.1% above its estimated GF Value™ of CHF40.77. GuruFocus considers Cosmo NV to be Significantly Overvalued.

Key valuation signals for XSWX:CMHC:

  • 5-Year Dividend Growth Rate: 0.00%
  • GF Value™: CHF40.77 vs. price of CHF57.10 (40.1% above fair value)
  • GF Score™: 81/100 with 3 warning signs

No single metric tells the full story. See the XSWX:CMHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cosmo NV Business Description

Address 91/94 North Wall Quay, 7th Floor, One North Dock, Dublin, IRL, D01 H7V7
Cosmo NV is is a life sciences company. The company is focused on MedTech AI, dermatology, gastrointestinal diseases, and contract development and manufacturing (CDMO). The company designs, develops, and manufactures solutions to address critical medical needs. Its technologies are trusted by international pharmaceutical and MedTech companies and reach patients and healthcare providers around the world. The product pipeline includes Eleview, GI Genius, Winlevi, Lialda, Uceris, and others.
81GF Score

Get the complete analysis for XSWX:CMHC

5-Year Dividend Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF57.10
Price
CHF40.77
GF Value